Qfitlia™ (fitusiran) Prevents or reduces bleeding in hemophilia A or B through an approved antithrombin-lowering RNAi medicine discovered by Alnylam and licensed to Sanofi.
Visit productCosigns Received
Be the first Cosign
Put your name behind Qfitlia™ (fitusiran).
Add it to your Products I use list and share why you use it.